NCT03673228

Brief Summary

Hospitalization for elective knee or hip replacement surgery presents an outstanding opportunity to motivate people to quit smoking, because it provides an opportunity to encourage patients to remain smoke-free as they proactively quit to optimize their surgery outcomes. This study will conduct a comparative effectiveness trial of patients who quit smoking pre-operatively, comparing the current standard of care with a novel comprehensive relapse prevention intervention guided by Marlatt's Relapse Prevention Model.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

September 17, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

January 15, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 28, 2021

Completed
Last Updated

November 12, 2021

Status Verified

November 1, 2021

Enrollment Period

2 years

First QC Date

August 27, 2018

Last Update Submit

November 10, 2021

Conditions

Outcome Measures

Primary Outcomes (6)

  • Self Reported Relapse Rate for Usual Care Arm

    Measured using the modified Dillman method

    3 Months

  • Self Reported Relapse Rate for Usual Care Arm

    Measured using the modified Dillman method

    6 Months

  • Self Reported Relapse Rate for Usual Care Arm

    Measured using the modified Dillman method

    12 Months

  • Self Reported Relapse Rate for relapse prevention intervention arm

    Measured using the modified Dillman method

    3 Months

  • Self Reported Relapse Rate for relapse prevention intervention arm

    Measured using the modified Dillman method

    6 Months

  • Self Reported Relapse Rate for relapse prevention intervention arm

    Measured using the modified Dillman method

    12 Months

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants randomized to the Intervention Arm will receive counseling that includes: * A Visit prior to discharge * Follow up calls after discharge * Text Messaging Support * Caregiver Support

Behavioral: Comprehensive Relapse Prevention InterventionDrug: Nicotine Replacement Therapy (NRT)

Standard treatment

ACTIVE COMPARATOR

Patients will receive current usual care.

Behavioral: Standard Treatment CounselingDrug: Nicotine Replacement Therapy (NRT)

Interventions

This intervention consists of 4 components: 1. Visit Prior to Discharge: counselor from research team will visit patient at hospital bedside to provide counseling 2. Follow up calls after discharge: 6 proactive counseling calls and initiate unlimited reactive calls to their counselor, at days 1,3,7,14,30,an 60 days after hospital visit 3. Text messaging support: patients will be registered in NCI's Smokefree TXT while in the hospital and will receive multiple daily messages, designed for someone who has already quit 4. Caregiver support: 10 minute training session to the caregiver on how to help patient prevent relapse by increasing self efficacy, maintaining motivation and dealing with high risk situations

Intervention Group

Participants will receive two 10 minute counseling calls from the staff of the preoperative counseling program during the first month after the hospital discharge

Standard treatment

Patients in both arms will be encouraged to receive NRT

Intervention GroupStandard treatment

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient Participants
  • Received preoperative smoking cessation counseling through Orthopedic Surgery Quit Smoking Program
  • Undergoing elective knee or hip arthroplasty surgery
  • Have not smoked any cigarettes in the week prior to admission and carbon monoxide 4 ppm46,47
  • Have a cell phone (for text messaging)
  • Provide informed consent in English
  • Caregiver participants:
  • Age ≥ 18 years
  • Be a caregiver of the patient participant
  • Provide informed consent in English

You may not qualify if:

  • Patients will be excluded if they used smokeless tobacco or an electronic cigarette in the last 30 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

SmokingSmoking Cessation

Interventions

Nicotine Replacement Therapy

Condition Hierarchy (Ancestors)

BehaviorHealth Behavior

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeutics

Study Officials

  • Scott Sherman, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2018

First Posted

September 17, 2018

Study Start

January 15, 2019

Primary Completion

January 28, 2021

Study Completion

January 28, 2021

Last Updated

November 12, 2021

Record last verified: 2021-11

Locations